Global Tourette Syndrome Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Tourette Syndrome Drug

• 1.1 Definition of Tourette Syndrome Drug
• 1.2 Tourette Syndrome Drug Segment by Type
  • 1.2.1 Global Tourette Syndrome Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 AZD-5213
  • 1.2.3 CPP-115
  • 1.2.4 Dutetrabenazine ER
  • 1.2.5 Ecopipam Hydrochloride
  • 1.2.6 Others
• 1.3 Tourette Syndrome Drug Segment by Applications
  • 1.3.1 Global Tourette Syndrome Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Research Center
  • 1.3.3 Hospital
  • 1.3.4 Clinic
  • 1.3.5 Others
• 1.4 Global Tourette Syndrome Drug Overall Market
  • 1.4.1 Global Tourette Syndrome Drug Revenue (2014-2025)
  • 1.4.2 Global Tourette Syndrome Drug Production (2014-2025)
  • 1.4.3 North America Tourette Syndrome Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Tourette Syndrome Drug Status and Prospect (2014-2025)
  • 1.4.5 China Tourette Syndrome Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Tourette Syndrome Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Tourette Syndrome Drug Status and Prospect (2014-2025)
  • 1.4.8 India Tourette Syndrome Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Tourette Syndrome Drug
• 2.3 Manufacturing Process Analysis of Tourette Syndrome Drug
• 2.4 Industry Chain Structure of Tourette Syndrome Drug

3 Development and Manufacturing Plants Analysis of Tourette Syndrome Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Tourette Syndrome Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Tourette Syndrome Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Tourette Syndrome Drug Production and Capacity Analysis
• 4.2 Tourette Syndrome Drug Revenue Analysis
• 4.3 Tourette Syndrome Drug Price Analysis
• 4.4 Market Concentration Degree

5 Tourette Syndrome Drug Regional Market Analysis

• 5.1 Tourette Syndrome Drug Production by Regions
  • 5.1.1 Global Tourette Syndrome Drug Production by Regions
  • 5.1.2 Global Tourette Syndrome Drug Revenue by Regions
• 5.2 Tourette Syndrome Drug Consumption by Regions
• 5.3 North America Tourette Syndrome Drug Market Analysis
  • 5.3.1 North America Tourette Syndrome Drug Production
  • 5.3.2 North America Tourette Syndrome Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Tourette Syndrome Drug Import and Export
• 5.4 Europe Tourette Syndrome Drug Market Analysis
  • 5.4.1 Europe Tourette Syndrome Drug Production
  • 5.4.2 Europe Tourette Syndrome Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Tourette Syndrome Drug Import and Export
• 5.5 China Tourette Syndrome Drug Market Analysis
  • 5.5.1 China Tourette Syndrome Drug Production
  • 5.5.2 China Tourette Syndrome Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Tourette Syndrome Drug Import and Export
• 5.6 Japan Tourette Syndrome Drug Market Analysis
  • 5.6.1 Japan Tourette Syndrome Drug Production
  • 5.6.2 Japan Tourette Syndrome Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Tourette Syndrome Drug Import and Export
• 5.7 Southeast Asia Tourette Syndrome Drug Market Analysis
  • 5.7.1 Southeast Asia Tourette Syndrome Drug Production
  • 5.7.2 Southeast Asia Tourette Syndrome Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Tourette Syndrome Drug Import and Export
• 5.8 India Tourette Syndrome Drug Market Analysis
  • 5.8.1 India Tourette Syndrome Drug Production
  • 5.8.2 India Tourette Syndrome Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Tourette Syndrome Drug Import and Export

6 Tourette Syndrome Drug Segment Market Analysis (by Type)

• 6.1 Global Tourette Syndrome Drug Production by Type
• 6.2 Global Tourette Syndrome Drug Revenue by Type
• 6.3 Tourette Syndrome Drug Price by Type

7 Tourette Syndrome Drug Segment Market Analysis (by Application)

• 7.1 Global Tourette Syndrome Drug Consumption by Application
• 7.2 Global Tourette Syndrome Drug Consumption Market Share by Application (2014-2019)

8 Tourette Syndrome Drug Major Manufacturers Analysis

• 8.1 Abide Therapeutics Inc
  • 8.1.1 Abide Therapeutics Inc Tourette Syndrome Drug Production Sites and Area Served
  • 8.1.2 Abide Therapeutics Inc Product Introduction, Application and Specification
  • 8.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Catalyst Pharmaceuticals Inc
  • 8.2.1 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
  • 8.2.2 Catalyst Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Neurocrine Biosciences Inc
  • 8.3.1 Neurocrine Biosciences Inc Tourette Syndrome Drug Production Sites and Area Served
  • 8.3.2 Neurocrine Biosciences Inc Product Introduction, Application and Specification
  • 8.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Psyadon Pharmaceuticals Inc
  • 8.4.1 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
  • 8.4.2 Psyadon Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Reviva Pharmaceuticals Inc
  • 8.5.1 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
  • 8.5.2 Reviva Pharmaceuticals Inc Product Introduction, Application and Specification
  • 8.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Synchroneuron Inc
  • 8.6.1 Synchroneuron Inc Tourette Syndrome Drug Production Sites and Area Served
  • 8.6.2 Synchroneuron Inc Product Introduction, Application and Specification
  • 8.6.3 Synchroneuron Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Teva Pharmaceutical Industries Ltd
  • 8.7.1 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Sites and Area Served
  • 8.7.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
  • 8.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Therapix Biosciences Ltd
  • 8.8.1 Therapix Biosciences Ltd Tourette Syndrome Drug Production Sites and Area Served
  • 8.8.2 Therapix Biosciences Ltd Product Introduction, Application and Specification
  • 8.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Tourette Syndrome Drug Market

• 9.1 Global Tourette Syndrome Drug Market Trend Analysis
  • 9.1.1 Global Tourette Syndrome Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Tourette Syndrome Drug Regional Market Trend
  • 9.2.1 North America Tourette Syndrome Drug Forecast 2019-2025
  • 9.2.2 Europe Tourette Syndrome Drug Forecast 2019-2025
  • 9.2.3 China Tourette Syndrome Drug Forecast 2019-2025
  • 9.2.4 Japan Tourette Syndrome Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Tourette Syndrome Drug Forecast 2019-2025
  • 9.2.6 India Tourette Syndrome Drug Forecast 2019-2025
• 9.3 Tourette Syndrome Drug Market Trend (Product Type)
• 9.4 Tourette Syndrome Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Tourette Syndrome Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List